The Current Ratio as of November 2024 (TTM) for Hoth Therapeutics, Inc. (HOTH) is 14.62

According to Hoth Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 14.62. This represents a change of 20.78% compared to the average of 12.11 of the last 4 quarters.

Hoth Therapeutics, Inc. (HOTH) Historical Current Ratio (quarterly & annually)

How has HOTH Current Ratio performed in the past?

The mean historical Current Ratio of Hoth Therapeutics, Inc. over the last ten years is 11.22. The current 14.62 Current Ratio has changed 12.93% with respect to the historical average. Over the past ten years (40 quarters), HOTH's Current Ratio was at its highest in in the September 2019 quarter at 163.29. The Current Ratio was at its lowest in in the June 2017 quarter at 0.

Hoth Therapeutics, Inc. (HOTH) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Hoth Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Hoth Therapeutics, Inc. (HOTH) Average Current Ratio

How has HOTH Current Ratio performed in the past?

The current Current Ratio of Hoth Therapeutics, Inc. (HOTH) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Hoth Therapeutics, Inc. (HOTH) Current Ratio vs. Peers

How is HOTH’s Current Ratio compared to its peers?

Hoth Therapeutics, Inc.’s Current Ratio is greater than Avenue Therapeutics, Inc. (4.30), greater than Revelation Biosciences, Inc. (1.10), greater than NeuroBo Pharmaceuticals, Inc. (2.94), less than Virax Biolabs Group Limited (25.94), greater than Zura Bio Limited (12.57), greater than Phio Pharmaceuticals Corp. (3.47), greater than Sonnet BioTherapeutics Holdings, Inc. (1.65), greater than 180 Life Sciences Corp. (0.58), greater than Cardio Diagnostics Holdings, Inc. (5.69), greater than Baudax Bio, Inc. (0.07), greater than TRACON Pharmaceuticals, Inc. (0.66), greater than Aditxt, Inc. (0.07), greater than Quoin Pharmaceuticals, Ltd. (3.35), greater than Allarity Therapeutics, Inc. (2.01), greater than Kiromic BioPharma, Inc. (0.35), greater than Biodexa Pharmaceuticals Plc (2.16), greater than Blue Water Vaccines, Inc. (0.54), greater than Hillstream BioPharma, Inc. (2.25), less than Kiora Pharmaceuticals, Inc. (19.22),

Build a custom stock screener for Hoth Therapeutics, Inc. (HOTH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hoth Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Hoth Therapeutics, Inc. (HOTH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Hoth Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.